Want to see TSE:XCX full AI Analyst Report?
Top Page
Greenrise Global Brands Inc
(XCX)
Select Model
Select Model
Rating:41Neutral
Price Target:
C$0.01
▲(0.00% Upside)
Action:Upgraded
Date:12/30/25
The score is driven primarily by very weak financial performance (recurring losses, negative equity, and a thin asset base relative to debt) and pressured/volatile cash generation. Valuation is also unattractive to assess due to negative earnings and no dividend data, while technicals cannot be evaluated with the indicators provided.
Positive Factors
Strategic Partnerships
Strategic partnerships enhance distribution capabilities and market penetration, potentially driving long-term revenue growth and brand recognition.
Negative Factors
High Leverage
High leverage and negative equity pose significant financial risks, limiting operational flexibility and increasing vulnerability to economic downturns.
Read all positive and negative factors
Positive Factors
Negative Factors
Strategic Partnerships
Strategic partnerships enhance distribution capabilities and market penetration, potentially driving long-term revenue growth and brand recognition.
Read all positive factors
Greenrise Global Brands Inc (XCX) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$258.28K
Dividend YieldN/A
Average Volume (3M)5.52K
Price to Earnings (P/E)―
Beta (1Y)-1.26
Revenue GrowthN/A
EPS Growth-406.12%
CountryCA
Employees250
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)-0.02
Shares Outstanding51,655,370
10 Day Avg. Volume2,200
30 Day Avg. Volume5,516
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)-0.44
Price to Sales (P/S)0.00
P/FCF Ratio-6.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Greenrise Global Brands Inc Business Overview & Revenue Model
Company Description
Greenrise Global Brands Inc., operating through its various subsidiaries, serves as a pharmaceutical distributor, providing medical cannabis products to pharmacies throughout Germany. The company also offers a broad selection of CBD-infused items,...
How the Company Makes Money
Greenrise Global Brands Inc generates revenue primarily through the sale of its cannabis and hemp-based products. These products are sold through various channels, including direct-to-consumer sales, retail partnerships, and online platforms. The ...
Greenrise Global Brands Inc Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
8
Very Negative
Cash Flow
18
Very Negative
| Breakdown | TTM | Mar 2025 | Mar 2024 | Jun 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 452.87K | 105.20K |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 43.32K | -153.00 |
| EBITDA | -597.32K | -542.80K | -177.72K | -744.80K | -2.60M | -2.06M |
| Net Income | -807.54K | -722.06K | -298.91K | -2.32M | -3.64M | -2.11M |
Balance Sheet | ||||||
| Total Assets | 1.30K | 93.53K | 441.82K | 1.25M | 252.94K | 371.56K |
| Cash, Cash Equivalents and Short-Term Investments | 1.30K | 13.53K | 31.53K | -619.68K | 27.45K | 60.45K |
| Total Debt | 2.73M | 2.62M | 2.80M | 3.15M | 1.90M | 1.08M |
| Total Liabilities | 2.88M | 2.79M | 3.06M | 3.56M | 2.26M | 1.34M |
| Stockholders Equity | -2.88M | -2.70M | -2.61M | -2.32M | -2.00M | -972.61K |
Cash Flow | ||||||
| Free Cash Flow | -87.44K | -176.13K | 199.35K | -1.08M | -1.95M | -1.88M |
| Operating Cash Flow | -87.44K | -176.13K | 199.35K | -1.08M | -1.89M | -1.83M |
| Investing Cash Flow | 87.90K | 60.40K | 387.50K | -531.00K | -63.15K | 45.43K |
| Financing Cash Flow | -16.43K | 97.73K | -534.73K | 1.51M | 1.92M | 1.63M |
Greenrise Global Brands Inc Peers Comparison
UnderperformOutperform
Sector (51)
TSE:XCX
Greenrise Global Brands Inc
0.01
0.00
0.00%
TSE:GHG
Global Hemp
0.02
0.00
0.00%
TSE:CNTR
CENTR Brands
0.03
-0.02
-37.50%
TSE:XBRA
Xebra Brands Ltd.
0.01
-0.01
-50.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.